Immix Biopharma (IMMX) Cash & Equivalents (2020 - 2026)
Immix Biopharma (IMMX) posted Cash & Equivalents of $225.49 million for Q2 2026, compared with $11.64 million a year earlier and up 184.5% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Immix Biopharma's Cash & Equivalents came in at $93.93 million, up 431.2% from FY2024.
- Annual Cash & Equivalents has increased for three consecutive years, with a five-year compound annual growth rate of 199.3% (FY2020 to FY2025).
- In prior years, Immix Biopharma's Cash & Equivalents was $17.68 million in FY2024 (+1.0%), $17.51 million in FY2023 (+30.3%), $13.44 million in FY2022 (-23.8%) and $17.64 million in FY2021.
- The Q2 2026 figure stands as the highest quarterly Cash & Equivalents in data going back to Q4 2020.
- On a year-over-year basis, Cash & Equivalents increased in four of the last seven quarters, with growth averaging 102.0%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q4 2025, with growth of 431.2%; the weakest was Q2 2025, with a decline of 51.5%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $79.25 million (Q1 2026), $93.93 million (Q4 2025) and $15.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Immix Biopharma | 731.81 Mn | 731.81 Mn | - | 225.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 225.49 Mn |
| Mar 31, 2026 | 79.25 Mn |
| Dec 31, 2025 | 93.93 Mn |
| Sep 30, 2025 | 15.95 Mn |
| Jun 30, 2025 | 11.64 Mn |
| Mar 31, 2025 | 15.92 Mn |
| Dec 31, 2024 | 17.68 Mn |
| Sep 30, 2024 | 19.69 Mn |
| Jun 30, 2024 | 23.98 Mn |
| Mar 31, 2024 | 29.32 Mn |
| Dec 31, 2023 | 17.51 Mn |
| Sep 30, 2023 | 19.58 Mn |
| Jun 30, 2023 | 12.65 Mn |
| Mar 31, 2023 | 11.46 Mn |
| Dec 31, 2022 | 13.44 Mn |
| Sep 30, 2022 | 16.92 Mn |
| Jun 30, 2022 | 18.40 Mn |
| Mar 31, 2022 | 19.06 Mn |
| Dec 31, 2021 | 17.64 Mn |
| Dec 31, 2020 | 391,086.00 |
API Access
Immix Biopharma Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();